The Missouri Division of Cannabis Regulation (DCR) has recently taken a significant step in the cannabis industry by issuing a recall of more than 62,000 cannabis products manufactured by Delta Extraction, LLC. The reason behind this recall lies in the fact that these products were not being compliantly tracked in the statewide track and trace system known as METRC. This failure to adhere to tracking protocols created a situation where the DCR could not verify the origins of these products – whether they were sourced from marijuana cultivated within Missouri and had undergone the necessary testing procedures.
The scope of this recall encompasses a wide range of cannabis-infused products, including tinctures, vape cartridges, gel capsules, tablets, and other similar items. To ensure public safety, the DCR has strongly recommended that consumers who have purchased any of these affected products take appropriate action. They can either discard these items or return them to the dispensary where they were originally purchased. Importantly, the DCR has reassured consumers that these returns will not impact their established monthly purchase limits, providing a degree of comfort to those affected.
The DCR has been proactive in promoting awareness among consumers regarding the risks associated with marijuana products that have not been appropriately tracked in the METRC system. By urging consumers to follow the prescribed disposal or return procedures, the DCR is attempting to safeguard the well-being of the public.
Additionally, the DCR has emphasized the significance of reporting any adverse reactions related to the use of these products. They have provided channels for reporting such reactions, including email and an online complaint form, underlining their commitment to ensuring consumer safety.
The context leading up to this recall involves a lengthy hearing at the Administrative Hearing Commission. During this hearing, Delta Extraction challenged the immediate suspension of its license by the Missouri Department of Health and Senior Services (DHSS). The suspension followed the discovery that Delta Extraction had incorporated out-of-state hemp-derived THCa into its marijuana products. THCa is the non-psychoactive compound in marijuana that converts into THC when heated, producing the characteristic “high.”
Delta Extraction’s representative, Jack Maritz, asserted that the distillation process allowed for the utilization of out-of-state hemp-derived THCa. The company’s position was based on previous state regulations that seemed to permit this practice. However, the state counterargued that recent regulations had clarified the prohibition of such practices. The outcome of the hearing remains pending, as the Administrative Hearing Commission has yet to decide on the reinstatement of Delta Extraction’s license.
Rachael Herndon, Delta’s chief operational officer, highlighted the adverse effects of the license suspension on the company’s reputation and financial standing. She stated, “Our reputation was damaged, and we had over $10 million in product on our site immediately locked up.”
This recall serves as a poignant reminder to both cannabis producers and consumers about the ever-evolving landscape of rules and regulations in the cannabis industry. The rapid shifts in policies underline the necessity for all stakeholders – including manufacturers, dispensaries, patients, and consumers – to remain diligently informed about the most current guidelines and procedures. By staying up-to-date, the industry can collectively work towards maintaining high standards of safety and compliance.
EXPLORE MORE NEWS